Best-in-class vaccines, built on one platform

Protein cages are synthetic virus-like particles that display biological material on their surface, or carry molecules such as nucleic acids or proteins into the cell. Our cages are programmable, which gives them significant potential as both drug delivery systems and vaccines.

Leading candidates

Product	Stage of development	Rationale for market entry	Phase start	Partner
Lyme Disease Vaccine	Design of VLP	There is currently no vaccine for Lyme disease A growing problem in the US and Western Europe The disease carries long-term complications More about Lyme disease	2025	Jagiellonian University
Universal Flu Vaccine	Challenge animal experiments	Elderly patients are recommended to have both Covid and flu boosters No combination option is available More about influenza	2024

Other pipeline assets

Product	Stage of development	Rationale for market entry	Phase start	Partner
RSV Vaccine	Design of VLP	RSV is a leading cause of severe respiratory illness in infants and older adults, and options for protecting patients remain limited More about RSV	2023
Drug Delivery System	Design of VLP	Programmable protein cages can carry nucleic acids or proteins into cells, opening a route to therapies that are hard to deliver today More about drug delivery systems	2024